REPRESENT-PF Registry

This pragmatic, prospective, single-arm, multi-center, observational registry will evaluate the safety and effectiveness of PFA for the treatment of atrial fibrillation in underrepresented minority patients using FDA approved Boston Scientific PFA catheters; all data collected will be standard of care.

NCT Number	NCT07535268
Lead Sponsor	Vivek Reddy Collaborators: Boston Scientific Corporation
Conditions	Persistent Atrial Fibrillation, Paroxysmal Atrial Fibrillation
Enrollment	275 participants
Start Date	2026-03-30
Primary Completion	2028-03-01 (estimated)
Study Completion	2028-03-01 (estimated)
Updated on ClinicalTrials.gov	2026-04-17